Search clinical trials for: Rare Hematological Disease

Total 383714 results

Assuta Medical Center
Laniado Hospital

Unknown

Identification of Hematological Malignancies and Therapy Predication Using microRNAs as a Diagnostic Tool

Lymphoma, B-Cell | Follicular Lymphoma | Multiple Myeloma | Hodgkin Lymphoma
AOP Orphan Pharmaceuticals AG

Completed

Anagrelide Retard vs. Placebo: Efficacy and Safety in "At-risk" Patients With Essential Thrombocythaemia (ARETA)

Essential Thrombocythaemia

Poland, Slovakia, Bulgaria, Russian Federation, Romania, Croatia, Lithuania, Austria, Ukraine
The University of Hong Kong

Completed

Study on Systemic and Airway Biomarkers in Haemopoietic Stem Cell Transplantation

Hematological Diseases

Hong Kong
Tragara Pharmaceuticals, Inc.

Completed

Phase 1 Study of TG02 Citrate in Patients With Advanced Hematological Malignancies (TG02-101)

Multiple Myeloma | AML | Blast Crisis | MDS | ALL

United States
Assistance Publique - Hôpitaux de Paris

Completed

The Use of Intensive Care in Critically Ill Cancer Haematological Patients: "TRIAL-OH"

Hematological Malignancies

France
AOP Orphan Pharmaceuticals AG
PharmaEssentia Corporation (Co-Sponsor for USA)

Completed

Study to Assess the Self-administration of AOP2014 Using a Pen, Developed for the Treatment of Polycythemia Vera Patients (PEN-PV)

Polycythemia Vera

Austria, Bulgaria, Czech Republic, France, Hungary, Poland, Slovakia, Ukraine
Memorial Sloan Kettering Cancer Center

Completed

A Myeloablative Conditioning Regimen and Total Body Irradiation Followed by the Transplantation for Patients With Hematological Malignancy

Leukemia | Cancer | Non-Hodgkin's Lymphoma | Myelodysplastic Syndrome

United States
Chinese PLA General Hospital

Unknown

Treatment of Relapsed and/or Chemotherapy Refractory CD33 Positive Acute Myeloid Leukemia by CART-33 (CART33)

Relapsed Adult Myeloid Leukemia | Chemotherapy Refractory Adult Myeloid Leukemia

China
Universitetshospitalernes Center for Sygepleje
Novo Nordisk A/S; University of Copenhagen; Danish Cancer Society; Lundbeck Foundation

Completed

Patient Activation, Counseling and Exercise - Acute Leukemia (PACE-AL) (PACE-AL)

Acute Leukemia

Denmark
Centre Antoine Lacassagne

Terminated

Evaluation of Patient Satisfaction With and Acceptance of Their Totally-implanted Central Venous Catheter (QASICC-EVA)

Malignant Mast Cell Tumors | Solid Organ Sites

France
University of Arkansas

Withdrawn

UARK 2006-28 Human Cord Blood Transplantation in Advanced Hematological Malignancies

Multiple Myeloma

United States
Mansoura University

Completed

Prognosis of Hematological Cancer Patient Underwent Mechanical Ventillation

Acute Respiratory Failure | Mechanical Ventilation | Hematological Malignancy

Egypt
Sorveglianza Epidemiologica Infezioni Fungine Emopatie...

Completed

Granulocyte Transfusions in Hematological Patients With Febrile Neutropenia

Sepsis | Fungal Infection | Neutropenia | Fever | Fever of Unknown Origin | Bacterial Infection | Hematological Neoplasms

Italy
Celgene Corporation

Terminated

Phase 1 Study of CC-486 in Japanese Subjects With Hematological Neoplasms

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Multiple Myeloma | Hodgkin Lymphoma | Chronic Myelomonocytic Leukemia | Non-Hodgkin Lymphoma

Japan
University Hospital Inselspital, Berne

Completed

Lipid Use, Nutrition, and Colitis in Patients With Hematological Malignancies (LUNCH1)

Colitis | AML | Mucositis

Switzerland
Gamida Cell -Teva Joint Venture Ltd.

Completed

Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy (ExCell)

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Non-Hodgkin's Lymphoma | Chronic Myeloid Leukemia | Hematologic Malignancies | Hodgkin's Disease | Lymphoid Leukemia

United States, Israel, Hungary, Italy, Spain
University Health Network, Toronto

Terminated

Study Evaluating the Tolerance and Biological Activity of Oral Clioquinol in Patients With Relapsed or Refractory Hematological Malignancy

Lymphoma, Non-Hodgkin | Acute Myeloid Leukemia | Multiple Myeloma | Hodgkin's Lymphoma | Chronic Lymphocytic Leukemia | Acute Lymphocytic Leukemia | Myelodysplasia

Canada
Hadassah Medical Organization

Unknown

Open-Label Study Designed to Evaluate the Safety and Preliminary Efficacy of ApoCell for the Prevention of Acute GvHD

Hematological Malignancies | Graft Versus Host Disease

Israel
City of Hope Medical Center
National Cancer Institute (NCI)

Terminated

Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to Treatment

Lymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Neoplasms

United States
Janssen-Cilag B.V.

Completed

ADVANCE: An Observational Study To Determine Bortezomib Safety and Effectiveness at First Relapse After Participation In First Line HOVON-49/50 Clinical Studies.

Multiple Myeloma | Hematological Neoplasms

Netherlands
Nanfang Hospital of Southern Medical University
Peking University People's Hospital; Sun Yat-sen University; Shanghai Zhongshan... and other collaborators

Unknown

MSC for Treatment of CMV Infection

Hematological Diseases | Stem Cell Transplantation, Hematopoietic | CMV Infection

China
Yonsei University

Completed

Micafungin Versus Intravenous Itraconazole as Empirical Antifungal Therapy for Febrile Neutropenic Patients With Hematological Diseases

Febrile Neutropenia | Hematological Diseases

Korea, Republic of
Nanfang Hospital of Southern Medical University
Peking University People's Hospital; Sun Yat-sen University; Guangzhou First... and other collaborators

Unknown

Megakaryocytic Progenitor Cells for Prophylaxis and Treatment of Thrombocytopenia

Thrombocytopenia | Hematological Diseases

China
Swedish Orphan Biovitrum
Amgen

Completed

Trial to Evaluate Palifermin in the Reduction of Acute Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Allogeneic Marrow/Peripheral Blood Progenitor Cell (PBPC) Transplantation

Hematologic Malignancies | Graft Versus Host Disease
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer

Lymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Small Intestine Cancer | Infection | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous Condition | Graft Versus Host Disease | Myelodysplastic/Myeloproliferative Neoplasms | Secondary Myelofibrosis

United States
National Hematological Society, Russia

Completed

A Russian Prospective Observational Study of Invasive Fungal Infections in Patients With Acute Leukemia and Hematopoietic Stem Cell Transplantation

Invasive Fungal Infections

Russian Federation
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI); National Institutes of Health (NIH)

Terminated

Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation

Graft Versus Host Disease

United States
Janssen Korea, Ltd., Korea

Completed

Observational Study Investigating the Response Rate of Itraconazole Injection in Treating Immunocompromised Patients

Neutropenia | Fever | Hematological Malignancies
Gemin X

Completed

Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) for the Treatment of Hematological Malignancies

Hematological Malignancies

United States, Canada
Dana-Farber Cancer Institute
Genentech, Inc.; Biogen

Completed

Rituximab for Prevention of Chronic GVHD

Hematological Malignancies

United States
Gilead Sciences

Terminated

A Trial of GS-9219 in Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin's Lymphoma (NHL) or Multiple Myeloma (MM)

Multiple Myeloma | Non-Hodgkin's Lymphoma | Chronic Lymphocytic Leukemia

United States, Czech Republic, Russian Federation
Janssen-Cilag B.V.

Completed

VALEO: A Post Authorization Study, Designed to Learn More About the Safety and Effectiveness of the Use of Bortezomib in the Netherlands

Multiple Myeloma | Hematological Neoplasms

Netherlands
Copenhagen University Hospital at Herlev

Completed

Can Treatment With Bismuth Reduce Toxicity to Chemotherapy and Radiotherapy? (Bismuth-PBH)

Leukemia | Multiple Myeloma | Hematological Malignancies | Hematological Diseases | Blood Diseases | Malignant Lymphoma

Denmark
Janssen Korea, Ltd., Korea

Completed

The Relationship of Defeverscence and Itraconazole Plasma Level Study in Immunocompromised Participants

Hematologic Neoplasms | Neutropenia | Fever
Rambam Health Care Campus

Completed

Busulfan Pharmacokinetic Analysis and GST Pharmacogenetic Profile in Adults Undergoing Hematological Stem Cell Transplantation

Acute Myeloid Leukemia
Asan Medical Center

Completed

Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological Cancer

Myelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative Neoplasms

Korea, Republic of
University Hospital Muenster
Pfizer; Hoffmann-La Roche

Completed

Value of the LightCycler® SeptiFast Test MGRADE for the Pathogen Detection in Neutropenic Hematological Patients

Sepsis | Hematologic Diseases | Neutropenia | Febrile Neutropenia

Germany
Northside Hospital, Inc.
Blood and Marrow Transplant Group of Georgia

Completed

Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

Lymphoma | Kidney Cancer | Myelodysplastic Syndromes | Leukemia | Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Diseases

United States
Chang Gung Memorial Hospital

Unknown

Registry of Febrile Neutropenia and Invasive Fungal Infections

Febrile Neutropenia | Hematological Disease | Fungal Infections

Taiwan
Centre Hospitalier Universitaire Vaudois
University Hospital, Basel, Switzerland

Completed

The Utility of Multiplex PCR for Detection of DNA in Neutropenic Patients With Hematological Malignancies (MedIso)

Neutropenia
M.D. Anderson Cancer Center

Completed

Megadose CD34 Selected Progenitor Cells for Transplantation in Patients With Advanced Hematological Malignant Diseases

Lymphoma | Leukemia

United States
Baylor College of Medicine
The Methodist Hospital Research Institute; Center for Cell and Gene Therapy...

Completed

Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients With Hematological Diseases

Hematologic Malignancy

United States
Chroma Therapeutics
Quintiles, Inc.

Completed

Safety and Anti-Disease Activity of Oral Tosedostat (CHR-2797) in Elderly Subjects With Refractory or Relapsed AML (OPAL)

Acute Myeloid Leukemia | AML

United States, Canada, Netherlands
Janssen Pharmaceutica N.V., Belgium

Completed

Retrospective Survey of Re-treatment With Bortezomib

Multiple Myeloma | Hematological Cancer

Greece
Novartis Pharmaceuticals

Completed

A Study to Determine the Absorption, Distribution, Metabolism, and Excretion of LBH589

Cancer Patients With Advanced Solid Tumors Including Lymphoma or Chronic Hematological Malignancies

United States
Duke University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Umbilical Cord Blood Stem Cell Transplantation in Adults With Advanced Blood Disorders or Cancer

Hematologic Neoplasms

United States
Universitetshospitalernes Center for Sygepleje
Novo Nordisk A/S; Lundbeck Foundation

Completed

Health Counseling and Exercise in Patients With Acute Leukemia - Pilot Study (PACE-AL)

Acute Leukemia

Denmark
Novartis Pharmaceuticals

Terminated

Glivec/Gleevec Pediatric (Age 1 to Less Than 4) PK Study in CML, Ph+ ALL Patients and Other Glivec/Gleevec® Indicated Hematological Disorders.

Chronic Myeloid Leukemia (CML) | Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL) | Other Glivec/Gleevec Indicated Hematological Disorders (HES, CEL, MDS/ MPN)

Russian Federation
Millennium Pharmaceuticals, Inc.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

An Open-Label Study to Assess the Effect of CYP3A4 Induction on the Pharmacokinetics of VELCADE (Bortezomib)

Multiple Myeloma | Non-Hodgkin's Lymphoma

Israel, Italy, Poland, South Africa, United Kingdom
Copenhagen University Hospital at Herlev

Unknown

A Study of the Efficacy of MK-0683 in Patients With Polycythaemia Vera and Essential Thrombocythaemia

Polycythemia Vera | Essential Thrombocythemia

Sweden, United Kingdom, Denmark, Netherlands

Search clinical trials for: Rare Hematological Disease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations